Big deals that may have once cleared U.S. regulatory reviews face a murkier future with a Democratic House majority and the Trump administration’s skeptical posture toward consolidation.
Big deals that may have once cleared U.S. regulatory reviews face a murkier future with a Democratic House majority and the Trump administration’s skeptical posture toward consolidation.